Although we clearly illustrated that HNK prevented the development of NASH-related HCC via the GR–MIG6–EGFR degradation pathway, further studies are needed to validate this disease prevention mechanism in humans. This evidence concerns the gene NR3C1 and metabolic dysfunction-associated steatohepatitis.